Hansa Biopharma AB (HNSA) — Tangible Net Worth Ratio
Hansa Biopharma AB (HNSA) has a Tangible Net Worth Ratio of 47.3% as of June 2023. This metric is calculated by deducting intangible assets (Skr95.94 Million) from net assets (Skr182.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of Hansa Biopharma AB for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hansa Biopharma AB Tangible Net Worth Ratio (2008–2022)
This chart shows how Hansa Biopharma AB's Tangible Net Worth Ratio has changed across 15 annual periods from 2008 to 2022. As of June 2023, the ratio stands at 47.3%, reflecting net assets of Skr182.18 Million with intangible assets of Skr95.94 Million SEK. Also explore net asset momentum of Hansa Biopharma AB to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Hansa Biopharma AB (2008–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Hansa Biopharma AB from 2008 to 2022, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Hansa Biopharma AB.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 92.2% | Skr602.91 Million | Skr46.87 Million | Skr1.69 Billion | ▼ -4.0 pp |
| 2021 | 96.2% | Skr757.57 Million | Skr28.76 Million | Skr1.01 Billion | ▼ -1.3 pp |
| 2020 | 97.5% | Skr1.24 Billion | Skr31.41 Million | Skr1.43 Billion | ▲ +3.4 pp |
| 2019 | 94.1% | Skr562.82 Million | Skr33.35 Million | Skr664.24 Million | ▼ -2.1 pp |
| 2018 | 96.1% | Skr859.88 Million | Skr33.20 Million | Skr944.82 Million | ▲ +1.5 pp |
| 2017 | 94.6% | Skr630.66 Million | Skr33.75 Million | Skr680.41 Million | ▲ +7.5 pp |
| 2016 | 87.1% | Skr283.69 Million | Skr36.55 Million | Skr310.67 Million | ▲ +4.3 pp |
| 2015 | 82.8% | Skr211.53 Million | Skr36.33 Million | Skr224.09 Million | ▲ +56.9 pp |
| 2014 | 25.9% | Skr49.80 Million | Skr36.90 Million | Skr54.31 Million | ▲ +14.4 pp |
| 2013 | 11.5% | Skr45.68 Million | Skr40.42 Million | Skr50.78 Million | ▼ -24.7 pp |
| 2012 | 36.2% | Skr63.24 Million | Skr40.37 Million | Skr65.80 Million | ▼ -60.4 pp |
| 2011 | 96.6% | Skr34.71 Million | Skr1.19 Million | Skr40.90 Million | ▼ -0.6 pp |
| 2010 | 97.2% | Skr32.17 Million | Skr898.50K | Skr37.80 Million | ▼ -2.8 pp |
| 2009 | 100.0% | Skr24.92 Million | Skr0.00 | Skr38.15 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Skr40.73 Million | Skr0.00 | Skr44.87 Million | — |